News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2024-03-20 4:31:26 am 23andMe Initiates Phase 1 Clinical Trial for its Dual Mechanism Antibody, 23ME-01473, Targeting ULBP6 GlobeNewsWire
2024-03-19 5:0:0 am 23andMe Launches New Feature Connecting Customers to Historical Individuals from Hundreds and Even Thousands of Years Ago GlobeNewswire
2024-03-06 4:30:0 am 23andMe Launches New Genetic Reports on Common Forms of Cancer GlobeNewswire
2024-03-05 1:30:0 pm 23andMe Announces Three Presentations from Clinical-Stage Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2024 GlobeNewswire
2024-02-23 2:15:14 am 20 Most Valuable Digital Health Companies In The US Insider Monkey
2024-02-13 6:53:0 am Is 23andMe Stock a Smart Buy Right Now? Motley Fool
2024-02-09 4:21:50 am 23andMe Holding Third Quarter 2024 Earnings: US$0.58 loss per share (vs US$0.20 loss in 3Q 2023) Simply Wall St.
2024-02-08 10:13:0 am 23andMe Stock Slides After DNA-Testing Company's Disappointing Results The Wall Street Journal
2024-02-08 5:59:34 am 23andMe Holding Co. (NASDAQ:ME) Q3 2024 Earnings Call Transcript Insider Monkey
   

Please consider a small donation if you think this website provides you with relevant information